Headings in table in RevMan	Proposed subheadings
Methods	Study design	Parallel group RCT, i.e. people randomised to treatment Paired eye or intra‐individual RCT, i.e. eyes randomised to treatment Cluster RCT, i.e. communities randomised to treatment Cross‐over RCT Other
	Eyes	One eye included in study Indicating how the eye was selected Two eyes included in study, both eyes received same treatment Indicating how data were analysed (best/worst/average/both) and adjusted for within person correlation/both and not adjusted for within person correlation Indicating if a mixture of one eye and two eyes were used Two eyes included in study, eyes received different treatments (pair matched) Indicating if a correct pair‐matched analysis was done
Participants	Country
	Setting
	Number of participants
	Number of men
	Number of women
	Average age
	Age range
	Ethnic group
	Inclusion criteria
	Exclusion criteria
	Eye movement disorders	Description of the type of eye movement disorder (III, IV, and VI cranial nerve palsy, reduced fixation, gaze holding, gaze palsy, saccadic problems, smooth pursuit problems, strabismus, nystagmus, reduced convergence or divergence, conjugate deviation, skew deviation), the deviation of eye movement (horizontal, vertical, torsional), and the severity of eye movement disorder (slight, small, moderate, marked; paralysis, paresis; monocular, binocular).
	Acquired brain injury	Description of type of brain injury, natural history, side of brain injury.
Interventions	Intervention Comparator	We provide a description of interventions given to each treatment group including, if relevant, the duration, intensity, frequency, or dose. We classify the type of intervention as restitution, compensation, pharmacological or substitution, type of brain injury, type of eye movement disorder, and the type of control as no treatment, placebo, control, or standard care. We document the professional background of the person providing the intervention (e.g. ophthalmologist, orthoptist).
Outcomes	List	We document the primary and secondary outcomes relevant to this review as listed in the Types of outcome measures section. Specifically, we document measurements showing change in angle of deviation and/or extent of eye movement range, measurement of binocular single vision, documentation of participant‐reported symptoms, documentation of questionnaires and adverse events. If a study has used a number of different methods of measuring the same outcome (e.g. prisms and degrees for measurement of ocular deviation), we note each method to be used for any subsequent analysis.
Notes	Date conducted	Indicating specific dates of recruitment of participants mm/yr to mm/yr
	Sources of funding
	Declaration of interest	Indicating any declarations of interest among the primary researchers
	Other	We record any important confounding variables. If a study includes more than two intervention groups, we also record the method of including these groups in any subsequent analysis.